We developed clinical practice guidelines to assess the individual risk-benefit profile of androgen replacement therapy in adult male hypogonadism (HG), defined by the presence of specific signs and symptoms and serum testosterone (T) below 12\ua0nmol/L
While US testosterone prescriptions have tripled in the last decade with lower trends in Europe, deb...
While US testosterone prescriptions have tripled in the last decade with lower trends in Europe, deb...
OBJECTIVE: The last decade has seen a proliferation in options for testosterone replacement. However...
We developed clinical practice guidelines to assess the individual risk-benefit profile of androgen ...
We developed clinical practice guidelines to assess the individual risk-benefit profile of androgen ...
Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italia...
Objective: We developed clinical practice guidelines to assess the individual risk-benefit profile o...
of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society...
To provide the evidence-based recommendations on the role of testosterone (T) on age-related symptom...
In these clinical practice guidelines, specific recom-mendations are made for determining the most e...
BACKGROUND: Evidence regarding functional hypogonadism, previously referred to as 'late-onset' hypog...
We examined the effects of androgen replacement therapy (ART) on scores of a comprehensive healthrel...
Male hypogonadism (MH) is a common endocrine disorder. However, uncertainties and variations in its ...
Purpose Management of late onset hypogonadism (LOH) is not homogenous. The aim of the study is to ob...
Hypogonadal men share a variety of signs and symptoms such as decreased muscle mass, osteopoenia, in...
While US testosterone prescriptions have tripled in the last decade with lower trends in Europe, deb...
While US testosterone prescriptions have tripled in the last decade with lower trends in Europe, deb...
OBJECTIVE: The last decade has seen a proliferation in options for testosterone replacement. However...
We developed clinical practice guidelines to assess the individual risk-benefit profile of androgen ...
We developed clinical practice guidelines to assess the individual risk-benefit profile of androgen ...
Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italia...
Objective: We developed clinical practice guidelines to assess the individual risk-benefit profile o...
of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society...
To provide the evidence-based recommendations on the role of testosterone (T) on age-related symptom...
In these clinical practice guidelines, specific recom-mendations are made for determining the most e...
BACKGROUND: Evidence regarding functional hypogonadism, previously referred to as 'late-onset' hypog...
We examined the effects of androgen replacement therapy (ART) on scores of a comprehensive healthrel...
Male hypogonadism (MH) is a common endocrine disorder. However, uncertainties and variations in its ...
Purpose Management of late onset hypogonadism (LOH) is not homogenous. The aim of the study is to ob...
Hypogonadal men share a variety of signs and symptoms such as decreased muscle mass, osteopoenia, in...
While US testosterone prescriptions have tripled in the last decade with lower trends in Europe, deb...
While US testosterone prescriptions have tripled in the last decade with lower trends in Europe, deb...
OBJECTIVE: The last decade has seen a proliferation in options for testosterone replacement. However...